KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Shares Outstanding (Diluted Average) (2017 - 2026)

Pfizer has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $5.7 billion for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) changed 0.37% to $5.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Mar 2026, changed 0.37% year-over-year, with the annual reading at $5.7 billion for FY2025, 0.23% changed from the prior year.
  • Shares Outstanding (Diluted Average) was $5.7 billion for Q1 2026 at Pfizer, roughly flat from $5.7 billion in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $5.8 billion in Q2 2022 and troughed at $5.6 billion in Q4 2023.
  • The 5-year median for Shares Outstanding (Diluted Average) is $5.7 billion (2025), against an average of $5.7 billion.
  • Year-over-year, Shares Outstanding (Diluted Average) rose 1.7% in 2022 and then fell 1.45% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.7 billion in 2022, then decreased by 0.42% to $5.7 billion in 2023, then decreased by 0.16% to $5.7 billion in 2024, then increased by 0.23% to $5.7 billion in 2025, then rose by 0.32% to $5.7 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Shares Outstanding (Diluted Average) are $5.7 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.7 billion (Q3 2025).